News

Nike's Options Activity: Trends and Analyst Insights Revealed

Nike's Options Activity: Trends and Analyst Insights Revealed

Nike Options Activity: What Investors Should Watch

Investors have leaned noticeably bearish on Nike (NKE) lately—a tone worth noting if you track the stock. Public options data shows a flurry of activity around NKE, hinting that something may be brewing beneath the surface. The traders behind these moves aren’t named, but the size and pace of orders often foreshadow shifts in the stock’s path.

Today’s review flags an active options tape for Nike: 17 standout prints crossed the tape, with sentiment split—about 35% of the flow read as bullish and 52% skewed bearish. The takeaway: positioning looks mixed overall, but it tilts negative.

What the Options Market Is Pricing In

Recent options positioning helps map out expected stock moves. Based on where volume and open interest clustered, larger players have focused on strikes implying a rough $50 to $90 range for Nike over the past quarter. That kind of targeting usually points to defined risk-reward setups rather than guesswork.

Reading Volume and Open Interest

Volume tells you what traded today; open interest shows what’s still open after the close. Watching both gives traders a sense of liquidity and where attention is building across Nike’s strikes. Over the past 30 days, tracking the ebb and flow in calls and puts has offered a running read on sentiment and how traders are adjusting to new information.

Snapshot: Nike’s Options Pulse

The latest snapshot of Nike’s options shows notable activity in both calls and puts. Looking at how these trades line up across expirations and strikes can help frame potential paths for the stock—near term and out on the calendar.

Highlights From Recent Large Trades

Here are three of the larger Nike option prints spotted recently:

Symbol: NKE
PUT/CALL: PUT
Trade Type: TRADE
Sentiment: BULLISH
Expiration Date: 10/18/24
Ask: $2.35
Bid: $2.27
Price: $2.30
Strike Price: $75.00
Total Trade Price: $115.0K
Open Interest: 9.0K
Volume: 531

Symbol: NKE
PUT/CALL: CALL
Trade Type: SWEEP
Sentiment: BULLISH
Expiration Date: 12/20/24
Ask: $3.50
Bid: $3.40
Price: $3.50
Strike Price: $85.00
Total Trade Price: $114.7K
Open Interest: 2.5K
Volume: 859

Symbol: NKE
PUT/CALL: CALL
Trade Type: TRADE
Sentiment: BEARISH
Expiration Date: 01/17/25
Ask: $8.60
Bid: $8.55
Price: $8.55
Strike Price: $75.00
Total Trade Price: $85.5K
Open Interest: 7.5K
Volume: 113

About Nike

Nike is the world’s leading athletic footwear and apparel brand, with strength across categories like basketball, running, and football (soccer). Footwear generates roughly two-thirds of total sales. Its portfolio includes Jordan, known for premium athletic footwear, and Converse, a staple in casual shoes. Nike sells through company-owned stores, franchise partners, and third-party retailers, and integrates e-commerce across more than 40 countries. Most production comes from external manufacturers located in over 30 countries. Founded in 1964, Nike is headquartered in Beaverton, Oregon.

With that backdrop, here’s where things stand right now for the stock.

Nike’s Current Setup

  • NKE last traded at $77.77, down 2.16%, on volume of 5,737,203 shares. That price action sets the tone for near-term sentiment.
  • Relative Strength Index (RSI) readings look neutral—neither stretched to the upside nor washed out to the downside.
  • The next earnings report is approaching and expected soon, a typical catalyst for repricing.

What Recent Analysts Are Saying

Over the past month, three analysts weighed in with an average price target of $84.00. The views vary, and that spread matters:

  • Stifel reiterated a Hold with a $79 target.
  • Piper Sandler moved to Neutral and set an $80 target.
  • Williams Trading turned more positive, upgrading to Buy with a $93 target.

Options can be demanding—position sizing, timing, and discipline all matter—but they also offer flexible ways to express a view. Experienced traders tend to iterate: they learn, adjust their structures, lean on tools, and stay aware as the market shifts.

Frequently Asked Questions

What does the recent bearish options flow imply for Nike?

It suggests a cautious tone. With 52% of tracked activity leaning bearish (and 35% bullish), traders appear positioned for potential downside or volatility, even as opinions remain mixed.

What’s Nike’s latest stock price and move?

Nike most recently traded at $77.77, down 2.16%, on volume of 5,737,203 shares. That snapshot frames the day’s pressure on the stock.

How are analysts framing Nike’s outlook?

Views are split. The average target across three recent notes sits at $84.00, with ratings ranging from Hold and Neutral to an upgraded Buy.

Why do volume and open interest matter in options?

They help gauge participation and focus. Volume shows what traded today, while open interest shows how many contracts remain open—useful for spotting where attention and liquidity cluster.

Is trading Nike options risky?

Yes. Options carry risk and require planning. That said, careful sizing, ongoing education, and staying alert to market changes can help manage those risks.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 184

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 295

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 153

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 168

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading

Top 5 Most Recently Viewed Articles

Telenor Group's Q3 2024 Results: Join Us for Insights

Updated Category News Views 304

Join Telenor Group for a Detailed Overview of Q3 2024 Results Telenor Group invites you to participate in the forthcoming results announcement for the third quarter of 2024. This event is an exciting opportunity to gain crucial insights into the company's performance and strategic direction. Details of the Presentation The presentation is scheduled for a morning session,...

Continue Reading
Azafaros Secures Key Approvals for Phase 3 Trials of Nizubaglustat

Updated Category News Views 322

Azafaros Achieves Critical Milestones in Regulatory Approvals Azafaros B.V. has recently announced significant advancements regarding its lead asset, nizubaglustat, which has garnered orphan drug designation from both United States and European regulatory authorities. This designation is specifically for the treatment of GM1 gangliosidosis, a rare lysosomal storage...

Continue Reading
Refresco's Leadership Changes Set the Stage for Future Growth

Updated Category News Views 373

Refresco's Leadership Changes Set the Stage for Future Growth Refresco, a prominent independent beverage solutions provider, recently announced that its Chief Executive Officer, Hans Roelofs, will be retiring. This transition marks a significant moment not only for Hans but also for the company, which has been under his stewardship for nearly two decades. Hans Roelofs: A...

Continue Reading
How a $1000 Investment in Home Depot Would Have Grown

Updated Category News Views 148

Home Depot: A Strong Investment Choice Home Depot has proven itself as a robust performer in the stock market over the years. With an impressive market capitalization of $379.06 billion, it has outshone the market by approximately 6.8% annually. The average annual return of 19.17% that the company has generated is nothing short of remarkable. This growth exemplifies the...

Continue Reading
AI Stocks Face Market Correction Amid Recovery Clouds

Updated Category News Views 207

The Shift in AI Stock Momentum The exhilarating rally that captivated investors in the spring is now showing signs of fatigue. What we're witnessing is not merely a dip, but a significant reality check across global markets. Japanese indices experienced dramatic declines, with the Nikkei plummeting over 4%—its steepest single-day drop in recent memory. Traders are...

Continue Reading